Skip Navigation

A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care
Awards and Recognition

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.


Guided by our values, our employees work every day to make meaningful differences in healthcare. At the core of what we do is our most valuable resource - our people. Learn more about us.

Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Supporting healthcare transformation through the generation of real-world evidence.

Working closely with our members, we're developing products and services to solve your most complex challenges.

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

Compelling stories from the front lines of America’s health systems.

The proactive, predictive and behind-the-scenes insights you need to stay ahead in healthcare delivered monthly to your inbox.

Premier Suggests Refinements to Senate Finance Committee Drug Shortage Discussion Draft

Premier submitted comments to the Senate Finance Committee, applauding the lawmakers’ bipartisan work to seek a path forward on addressing the issue of drug shortages in the Medicare program and for recognizing the vital role that group purchasing organizations (GPOs) play in vetting quality manufacturers and combatting shortages. Premier’s response to the draft legislation focuses on opportunities to further refine the proposal to best serve the needs of patients. Specifically, Premier urges the Senate Finance Committee to consider amendments to the draft legislation that:

  • Aligns all timelines for Program Participants, Payment-Eligible Providers, and Applicable Generic Manufacturers to a three-year timeline;
  • Clarifies that minimum commitment volumes should be done at the National Drug Code (NDC) level;
  • Ensures there are a minimum of three Program Participants across various business sectors to ensure viable competition in the marketplace;
  • Creates a payment methodology for Program Participants that is a scalable flat fee based on the services provided;
  • Requires Program Participants to maintain an advisory committee comprised of individuals with clinical and/or supply chain expertise from Payment-Eligible Providers to help ensure that contracting decisions are being made in the best interest of patient care and supply chain resiliency;
  • Clarifies that a secondary manufacturer is not required to be added to contract if more than one manufacturer is unable to meet the stringent vetting requirements of the program;
  • Studies the downstream impact of removing 340B discount eligibility on the ability of a covered entity to provide care to underserved populations;
  • Prohibits Payment-Eligible Providers from seeking or accepting additional rebates, discounts, or other price concessions from Program Participants;
  • Refines the buffer inventory requirements to be more cohesive;
  • Permits Program Participants to centralize and collate reporting on behalf of Payment-Eligible Providers;
  • Considers outcomes measures that tie back to patient outcomes; and
  • Requires Applicable Generic Manufacturers to submit transparent quality and manufacturing data to Program Participants to facilitate product review and selection.
Login Register Change Registration